Space Technology and Advanced Research Systems, Inc.-1 Experiment Facility
Short Name:The short name or acronym of the facility. STaARS-1 EF
Facility Description
The Space Technology and Advanced Research Systems – 1 Experiment Facility (STaARS-1 EF) is a multipurpose facility that enables a broad range of experiments on the ISSInternational Space Station. STaARS-1 EF facilitates novel drug discovery, drug compound production, virulence modeling, and biofuel production. STaARS-1-EF supports bio-medical therapeutic markets through drug delivery system development, regenerative tissue engineering (stem cell technologies), and biofilm formation prevention. Within the energy markets, STaARS-1 EF supports studies targeting novel bio-fuel production through enhanced quality and quantity of multiple compounds.
Availability:The general availability status of the facility. Please contact the facility manager
ISS Environment:The facility location (internal or external to the ISS.) Internal
Owner:The entity that owns the facility. Craig Technologies
Operator/Implementation Partner:The entity or ISS National Lab Implementation Partner that operates the facility.
Craig Technologies
Developer(s):The entity, or entities, that developed the facility.
Craig Technologies
Facility Manager:The name of the facility manager and their organization.
Craig L. Walton,
Craig Technologies
Manager Email:The facility manager's email address.
lamontaerospace@gmail.com
Parent Facility:Any facility that is necessary to operate the facility described on this webpage. i.e., a parent facility is one level higher in the operational hierarachy. EXPRESS Rack
Child Facility:Facilities that can be operated within the facility described on this webpage.
Sponsoring Space Agency:The government space agency that sponsors investigations that use the facility. NASA
Equipment Category:"The facility's ISS National Lab equipment designation type. Designations include:
1. ISS National Lab Commercial Service Provider (CSP) Facility
2. Support Hardware
3. Capability ISS National Lab CSP Facility
Additional Information:Additional resources to learn more about the facility.
Past STaARS-1 EF investigations on NASA’s SSRE
STaARS BioScience-1
STaARS BioScience-3
STaARS BioScience-5
STaARS BioScience-7
STaARS BioScience-8-Gene Control Prime-EPICON
STaARS BioScience-8-Gene Control Prime-FARAGIS
STaARS BioScience-9
STaARS BioScience-11
STaARS BioScience-12
STaARS BioScience-15
STaARS BioScience-17
STaARS-iFUNGUS
jsc2019e041782 (7/25/2019) --- A preflight image of the KEU-RO experiment units for STaARS BioScience-3 experiment. The Spaceflight Effects on Vascular Endothelial and Smooth Muscle Cell Process (STaARS BioScience-3) investigation contributes to a greater understanding of cardiovascular disease (CVD) through the study of transcriptomics of vascular cells. Upon return from spaceflight, crew members often display alterations in their cardiovascular systems, similar to those suffering from CVD. The goal of this work is to elucidate the mechanism of vascular cell damage in the space environment by exposing vascular cells to spaceflight.